Association of Circulating Sclerostin Levels with Fat Mass and Metabolic Disease—Related Markers in Japanese Postmenopausal Women
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
CONTEXT: Wnt/β-catenin signaling is related to the pathogenesis of osteoporosis, diabetes, and metabolic diseases. Sclerostin is an inhibitor of Wnt/β-catenin signaling. However, there are few data regarding the relationship between sclerostin levels and metabolic disease. OBJECTIVE: This study aimed to identify the relationship between serum sclerostin levels, body composition markers, and the markers of metabolic disease. DESIGN, SETTING, AND PATIENTS: The present study is a cross-sectional study. We measured serum sclerostin levels in 352 Japanese postmenopausal women and analyzed the relationship of these levels with bone mineral density, abdominal fat mass, and biochemical markers. The mean (sd) age of the subjects was 65.5 (9.3) yr. RESULTS: Serum sclerostin levels were positively correlated with percentages of abdominal and gynoid fat. We also analyzed the association between serum sclerostin levels and biochemical markers related to metabolic diseases. Multivariate analysis revealed that the serum sclerostin levels were significantly correlated with the levels of low-density lipoprotein cholesterol and homocysteine. CONCLUSIONS: The circulating sclerostin levels were associated with fat mass. The circulating sclerostin levels were also correlated with low-density lipoprotein cholesterol and homocysteine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Amrein, K., Amrein, S., Drexler, C., Dimai, H. P., Dobnig, H., Pfeifer, K., Tomaschitz, A., Pieber, T. R., & Fahrleitner-Pammer, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2152 · Cited by 277
Behari, J., Yeh, T.-H., Krauland, L., Otruba, W., Cieply, B., Hauth, B., Apte, U., Wu, T., Evans, R., & Monga, S. P. S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090667 · Cited by 128
Cited by
Role and mechanism of action of sclerostin in bone
Delgado-Calle, J., Sato, A. Y., & Bellido, T. (2017) · Bone · doi:10.1016/j.bone.2016.10.007 · Cited by 443
The role of osteoblasts in energy homeostasis
Dirckx, N., Moorer, M. C., Clemens, T. L., & Riddle, R. C. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0246-y · Cited by 292
Cytokines and abnormal glucose and lipid metabolism
Shi, J., Fan, J., Su, Q., & Yang, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00703 · Cited by 282
“In humans, circulating levels of sclerostin are increased in T2D (140) and positively associated with BMI and fat mass (141).”
BackgroundThe osteocyte as a signaling cell
Delgado-Calle, J., & Bellido, T. (2022) · Physiological Reviews · doi:10.1152/physrev.00043.2020 · Cited by 261
Sclerostin in excessive drinkers: relationships with liver function and body composition
Martín González, C., Fernández Rodríguez, C. M., Abreu González, P., García Rodríguez, A., Alvisa Negrín, J. C., Cabañas Perales, E., González Navarrete, L., Vera Delgado, V. E., Ortega Toledo, P., & González Reimers, E. (2022) · Nutrients · doi:10.3390/nu14132574 · Cited by 9
“In this sense, sclerostin levels are related to insulin resistance [12], are higher in diabetics [13] and in patients affected by metabolic syndrome [9], and positively correlate with body fat [14,15], although (as with BMD or BMC) some discrepancy exists regarding this matter.”
BackgroundResult
Metadata
- Authors
- Urano, T., Shiraki, M., Ouchi, Y., & Inoue, S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-08
- Volume
- 97
- Issue
- 8
- Pages
- E1473-E1477
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2128594230
- Cited by
- 101
- References
- 4
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.